Dupilumab ocular side effects in patients with atopic dermatitis: a systematic review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dupilumab ocular side effects in patients with atopic dermatitis: a systematic review

Published:2022-02-17 Issue:6 Volume:36 Page:820-835
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Neagu N.¹^ORCID,Dianzani C.²,Avallone G.³^ORCID,Dell’Aquila C.⁴,Morariu S.‐H.¹,Zalaudek I.⁵,Conforti C.⁵^ORCID

Affiliation:

1. State Clinic of Dermatology Mureş County Hospital Tîrgu Mureş Romania

2. Plastic and Reconstructive Surgery Unit Campus Bio‐Medico University of Rome Rome Italy

3. Medical Sciences Department Section of Dermatology University of Turin Turin Italy

4. Department of Medical Surgical Sciences and Health Eye Clinic University of Trieste Trieste Italy

5. Dermatology Clinic Maggiore Hospital of Trieste Trieste Italy

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.17981

Reference78 articles.

1. Management of dupilumab‐associated conjunctivitis in atopic dermatitis;Aszodi N;J Dtsch Dermatol Ges J Ger Soc Dermatol,2019

2. Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis

3. Dupilumab after the 2017 approval for the treatment of atopic dermatitis: what's new and what's next?

4. Conjunctivitis in patients with atopic dermatitis treated with dupilumab;Ferreira S;Drugs Context,2020

5. Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dupilumab‐related ocular surface disorders in a paediatric cohort with atopic dermatitis, treated in a tertiary paediatric hospital in London;JEADV Clinical Practice;2024-08-14

2. Biologic and Small Molecule Therapy in Atopic Dermatitis;Biomedicines;2024-08-13

3. Continued contribution to atopic innovation with dupilumab;Current Opinion in Pediatrics;2024-08-09

4. Dupilumab in Patients with Atopic Dermatitis: A Multicentric, Long-Term, Real-World Portuguese Study;Dermatology and Therapy;2024-07-22

5. An Updated Reappraisal of Dupilumab in Children and Adolescents with Severe Asthma;Children;2024-07-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3